Medtech Archives - Page 94 of 99 - Life Sciences Times

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

June 13, 2025

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

June 13, 2025

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

June 12, 2025

THIS WEEK'S STORIES

IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

June 9, 2025

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

June 7, 2025

Enveric Biosciences Secures U.S. Patent for New Class of Low-Hallucinogenic Compounds Targeting Mental Health Disorders

June 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Viz.ai Receives FDA Clearance for First AI Tool to Quantify Subdural Hemorrhages

First Clinical Study Confirms Safety and Effectiveness of SeptAlign™ Implant for Treating Nasal Septal Deviation

SoundHealth’s SONU Band Receives FDA Approval for Pediatric Use in Treating Nasal Congestion and Allergies

ENvue Medical Secures U.S. Patent for Pediatric Feeding Tube Guidance System

BrainScope Unveils Next-Gen Deep Learning Platform and Expands Board to Advance Brain Health Innovation

Most Read

Robotic Pet Startup Tombot Raises $6.1 Million to Launch Therapeutic Companion for Seniors

FDA Approves Merck’s Keytruda for Perioperative Use in Certain Head and Neck Cancer Patients

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Astria Therapeutics Reports Strong Long-Term Results for Navenibart in Hereditary Angioedema Patients

EDITOR PICKS

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

THIS WEEK'S STORIES

IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

Vertex Highlights Potential of ALYFTREK in Cystic Fibrosis at European Conference

Enveric Biosciences Secures U.S. Patent for New Class of Low-Hallucinogenic Compounds Targeting Mental Health Disorders

POPULAR CATEGORY

ABOUT US

FOLLOW US